Helios

NHS Approves Revolutionary CRISPR Gene Therapy for Sickle Cell Disease

NHS Approves Revolutionary CRISPR Gene Therapy for Sickle Cell Disease In a landmark decision, the National Health Service (NHS) in England has approved the use of Casgevy, a groundbreaking CRISPR-based gene therapy, for patients aged 12 and older suffering from sickle cell disease (SCD) with recurrent vaso-occlusive crises. This approval marks a significant advancement in […]

HELIOS website goes live!

WG5 – Dissemination and outreach has just published the HELIOS website that you can visit here!